Audi Setiadi, Stuart E Turvey, Millan S Patel, Anthony Cooper, Sylvia Cheng, Anna Lehman, Florian Kuchenbauer, Anna F Lee, Michael S Kobor, Jill Mwenifumbo, Wyeth W Wasserman, Pascal M Lavoie, Mehul Sharma, Jefferson Terry, Meriam Waqas, Kate L Del Bel, Areesha Salman, Joshua Dalmann, Susan Lin, Christina Michalski, Bhavi P Modi, Ashish A Sharma, Henry Y Lu, Maggie P Fu
Journal: Blood 2022;140(17):1858-1874
PMID: 35789258
The discovery of humans with monogenic disorders has a rich history of generating new insights into biology. Here we report the first human identified with complete deficiency of nuclear factor of activated T cells 1 (NFAT1). NFAT1, encoded by NFATC2, mediates calcium-calcineurin signals that drive cell activation, proliferation, and survival. The patient is homozygous for a damaging germline NFATC2 variant (c.2023_2026delTACC; p.Tyr675Thrfs∗18) and presented with joint contractures, osteochondromas, and recurrent B-cell lymphoma. Absence of NFAT1 protein in chondrocytes caused enrichment in prosurvival and inflammatory genes. Systematic single-cell-omic analyses in PBMCs revealed an environment that promotes lymphomagenesis with accumulation of naïve B cells (enriched for oncogenic signatures MYC and JAK1), exhausted CD4+ T cells, impaired T follicular helper cells, and aberrant CD8+ T cells. This work highlights the pleiotropic role of human NFAT1, will empower the diagnosis of additional patients with NFAT1 deficiency, and further defines the detrimental effects associated with long-term use of calcineurin inhibitors.
© 2022 by The American Society of Hematology.
Full Text Sources:
Miscellaneous:
Molecular Biology Databases:
Research Materials:
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.